Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, U6 small nuclear 97, pseudogene (RNU6-97P) is a human pseudogene corresponding to a nonfunctional copy of the U6 small nuclear RNA gene[8][6][7]. U6 small nuclear RNA is a component of the spliceosome complex required for the splicing of pre-messenger RNA in eukaryotic cells[3]. However, as a pseudogene, RNU6-97P does not produce a functional product and is not considered a therapeutic target or a protein-coding gene. Like other pseudogenes, RNU6-97P may be transcribed, but it is generally believed to lack significant biological function; still, some pseudogenes elsewhere in the genome have shown potential regulatory roles, including involvement in gene expression modulation and interactions with microRNAs or as sources of regulatory RNAs[4]. At present, there is no evidence that RNU6-97P itself has a direct regulatory or disease-related function.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U6 small nuclear 97, pseudogene (RNU6-97P).